Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Newron Pharmaceuticals S.p.A.

https://www.newron.com/en

Latest From Newron Pharmaceuticals S.p.A.

Hengrui Takes Focused Approach Amid China Inc's Global Drive

China’s largest innovative domestic drug maker will only take global those products that play into its strengths, chairman Piaoyang Sun declares.

China Business Strategies

Acadia’s Trofinetide Shows Efficacy In Rett Syndrome, But Safety Looks Shaky

Trofinetide could be the first approved drug for Rett patients after hitting both co-primary endpoints in a Phase III trial, but high rates of diarrhea and vomiting raise questions.

Clinical Trials Rare Diseases

Abogen and Neurophth Lead China mRNA, Gene And Cell Therapy Funding Rush

Total of $571m raised in China from 10 venture capital and private equity funding deals betting heavily on mRNA and targeted oncology, as well as gene and cell therapies.

China Financing

AstraZeneca Rejigs Respiratory Franchise With Fresh Covis Deal

Having got hold of two COPD drugs from Spain's Almirall in 2014, AstraZeneca has passed Eklira and Duaklir onto old partner Covis Pharma as it focuses on more targeted respiratory therapies.

Respiratory Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Hunter-Fleming
    • NeuroNova AB
    • Newron Pharmaceuticals SpA
UsernamePublicRestriction

Register